2618 related articles for article (PubMed ID: 26136504)
1. Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target.
Yan Y; Zuo X; Wei D
Stem Cells Transl Med; 2015 Sep; 4(9):1033-43. PubMed ID: 26136504
[TBL] [Abstract][Full Text] [Related]
2. The Role of CD44 and Cancer Stem Cells.
Wang L; Zuo X; Xie K; Wei D
Methods Mol Biol; 2018; 1692():31-42. PubMed ID: 28986884
[TBL] [Abstract][Full Text] [Related]
3. Regulation of alternative splicing of CD44 in cancer.
Prochazka L; Tesarik R; Turanek J
Cell Signal; 2014 Oct; 26(10):2234-9. PubMed ID: 25025570
[TBL] [Abstract][Full Text] [Related]
4. Emerging functional markers for cancer stem cell-based therapies: Understanding signaling networks for targeting metastasis.
Marquardt S; Solanki M; Spitschak A; Vera J; Pützer BM
Semin Cancer Biol; 2018 Dec; 53():90-109. PubMed ID: 29966677
[TBL] [Abstract][Full Text] [Related]
5. Activation of Matrix Hyaluronan-Mediated CD44 Signaling, Epigenetic Regulation and Chemoresistance in Head and Neck Cancer Stem Cells.
Bourguignon LYW; Earle C; Shiina M
Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28837080
[TBL] [Abstract][Full Text] [Related]
6. CD44 is a multidomain signaling platform that integrates extracellular matrix cues with growth factor and cytokine signals.
Orian-Rousseau V; Sleeman J
Adv Cancer Res; 2014; 123():231-54. PubMed ID: 25081532
[TBL] [Abstract][Full Text] [Related]
7. Knock out CD44 in reprogrammed liver cancer cell C3A increases CSCs stemness and promotes differentiation.
Han S; Guo J; Liu Y; Zhang Z; He Q; Li P; Zhang M; Sun H; Li R; Li Y; Zeng W; Liu J; Lian L; Gao Y; Shen L
Oncotarget; 2015 Dec; 6(42):44452-65. PubMed ID: 26540347
[TBL] [Abstract][Full Text] [Related]
8. Stem cell programs in cancer initiation, progression, and therapy resistance.
Huang T; Song X; Xu D; Tiek D; Goenka A; Wu B; Sastry N; Hu B; Cheng SY
Theranostics; 2020; 10(19):8721-8743. PubMed ID: 32754274
[TBL] [Abstract][Full Text] [Related]
9. Cancer stem cells (CSCs) in cancer progression and therapy.
Najafi M; Farhood B; Mortezaee K
J Cell Physiol; 2019 Jun; 234(6):8381-8395. PubMed ID: 30417375
[TBL] [Abstract][Full Text] [Related]
10. Roles and targeting of the HAS/hyaluronan/CD44 molecular system in cancer.
Karousou E; Misra S; Ghatak S; Dobra K; Götte M; Vigetti D; Passi A; Karamanos NK; Skandalis SS
Matrix Biol; 2017 May; 59():3-22. PubMed ID: 27746219
[TBL] [Abstract][Full Text] [Related]
11. Redox regulation in stem-like cancer cells by CD44 variant isoforms.
Nagano O; Okazaki S; Saya H
Oncogene; 2013 Oct; 32(44):5191-8. PubMed ID: 23334333
[TBL] [Abstract][Full Text] [Related]
12. A CD44v
Hu J; Li G; Zhang P; Zhuang X; Hu G
Cell Death Dis; 2017 Mar; 8(3):e2679. PubMed ID: 28300837
[TBL] [Abstract][Full Text] [Related]
13. Sasa quelpaertensis Leaf Extract Inhibits Colon Cancer by Regulating Cancer Cell Stemness in Vitro and in Vivo.
Min SJ; Lim JY; Kim HR; Kim SJ; Kim Y
Int J Mol Sci; 2015 Apr; 16(5):9976-97. PubMed ID: 25941936
[TBL] [Abstract][Full Text] [Related]
14. The bad seed: Cancer stem cells in tumor development and resistance.
Koren E; Fuchs Y
Drug Resist Updat; 2016 Sep; 28():1-12. PubMed ID: 27620951
[TBL] [Abstract][Full Text] [Related]
15. Cancer stem cells: the promise and the potential.
Ajani JA; Song S; Hochster HS; Steinberg IB
Semin Oncol; 2015 Apr; 42 Suppl 1():S3-17. PubMed ID: 25839664
[TBL] [Abstract][Full Text] [Related]
16. CD44v8-10 is a cancer-specific marker for gastric cancer stem cells.
Lau WM; Teng E; Chong HS; Lopez KA; Tay AY; Salto-Tellez M; Shabbir A; So JB; Chan SL
Cancer Res; 2014 May; 74(9):2630-41. PubMed ID: 24618343
[TBL] [Abstract][Full Text] [Related]
17. Aberrant expression of cancer stem cell markers (CD44, CD90, and CD133) contributes to disease progression and reduced survival in hepatoblastoma patients: 4-year survival data.
Bahnassy AA; Fawzy M; El-Wakil M; Zekri AR; Abdel-Sayed A; Sheta M
Transl Res; 2015 Mar; 165(3):396-406. PubMed ID: 25168019
[TBL] [Abstract][Full Text] [Related]
18. Targeting Cancer Stem Cells in Castration-Resistant Prostate Cancer.
Yun EJ; Zhou J; Lin CJ; Hernandez E; Fazli L; Gleave M; Hsieh JT
Clin Cancer Res; 2016 Feb; 22(3):670-9. PubMed ID: 26490309
[TBL] [Abstract][Full Text] [Related]
19. Targeting cancer stem cell-specific markers and/or associated signaling pathways for overcoming cancer drug resistance.
Ranji P; Salmani Kesejini T; Saeedikhoo S; Alizadeh AM
Tumour Biol; 2016 Oct; 37(10):13059-13075. PubMed ID: 27561758
[TBL] [Abstract][Full Text] [Related]
20. Stem cell CD44v isoforms promote intestinal cancer formation in Apc(min) mice downstream of Wnt signaling.
Zeilstra J; Joosten SP; van Andel H; Tolg C; Berns A; Snoek M; van de Wetering M; Spaargaren M; Clevers H; Pals ST
Oncogene; 2014 Jan; 33(5):665-70. PubMed ID: 23318432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]